Breaking News

Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing

AGC Biologics scales up production to support Calypso’s clinical trials.

By: Contract Pharma

Contract Pharma Staff

Calypso Biotech is retaining the services of AGC Biologics for the development of the manufacturing process and the production of its clinical supply of GMP-grade CALY-002.   IL-15 is an immune checkpoint cytokine that controls inflammation, as well as the fate of multiple immune cells. It was recently recognized as a key factor in the survival of tissue-resident memory T cells, a population of immune cells involved in disease maintenance and recurrence. AGC Biologics has successfully developed ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters